Clinical Trial: A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Safety of a Bovine Thymus Nuclear Extract

U.S., Jan. 29 -- ClinicalTrials.gov registry received information related to the study (NCT06795945) titled 'A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Safety of a Bovine Thymus Nuclear Extract' on Jan. 06.

Brief Summary: The goal of this trial is to find out if Thymus Nuclear Extract is safe and well-tolerated in healthy men and women by testing three different dose levels and comparing the results to a placebo.

Study Start Date: Jan., 2025

Study Type: INTERVENTIONAL

Condition: Immunology

Intervention: DIETARY_SUPPLEMENT: TPG1

* Thymus Nuclear Extract Dose 1 (860 mg [2 tablets, 2x/day; total 4 tablets per day])

* Placebo (6 tablets, 2x/day; total 12 tablets per day)

DIETARY_SUPPLEMENT: TPG2

* ...